We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BIDU or HSTM: Which Is the Better Value Stock Right Now?
Read MoreHide Full Article
Investors with an interest in Internet - Services stocks have likely encountered both Baidu Inc. (BIDU - Free Report) and HealthStream (HSTM - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.
Baidu Inc. and HealthStream are sporting Zacks Ranks of #2 (Buy) and #3 (Hold), respectively, right now. Investors should feel comfortable knowing that BIDU likely has seen a stronger improvement to its earnings outlook than HSTM has recently. But this is just one piece of the puzzle for value investors.
Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.
Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.
BIDU currently has a forward P/E ratio of 9.09, while HSTM has a forward P/E of 51.23. We also note that BIDU has a PEG ratio of 2.17. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. HSTM currently has a PEG ratio of 4.27.
Another notable valuation metric for BIDU is its P/B ratio of 0.81. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. By comparison, HSTM has a P/B of 2.85.
Based on these metrics and many more, BIDU holds a Value grade of A, while HSTM has a Value grade of D.
BIDU has seen stronger estimate revision activity and sports more attractive valuation metrics than HSTM, so it seems like value investors will conclude that BIDU is the superior option right now.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
BIDU or HSTM: Which Is the Better Value Stock Right Now?
Investors with an interest in Internet - Services stocks have likely encountered both Baidu Inc. (BIDU - Free Report) and HealthStream (HSTM - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.
Baidu Inc. and HealthStream are sporting Zacks Ranks of #2 (Buy) and #3 (Hold), respectively, right now. Investors should feel comfortable knowing that BIDU likely has seen a stronger improvement to its earnings outlook than HSTM has recently. But this is just one piece of the puzzle for value investors.
Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.
Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.
BIDU currently has a forward P/E ratio of 9.09, while HSTM has a forward P/E of 51.23. We also note that BIDU has a PEG ratio of 2.17. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. HSTM currently has a PEG ratio of 4.27.
Another notable valuation metric for BIDU is its P/B ratio of 0.81. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. By comparison, HSTM has a P/B of 2.85.
Based on these metrics and many more, BIDU holds a Value grade of A, while HSTM has a Value grade of D.
BIDU has seen stronger estimate revision activity and sports more attractive valuation metrics than HSTM, so it seems like value investors will conclude that BIDU is the superior option right now.